These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6142250)

  • 1. Cholesterol lowering and the risk of coronary heart disease.
    Lancet; 1984 Mar; 1(8375):520. PubMed ID: 6142250
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol lowering and the risk of coronary heart disease.
    Lancet; 1984 Apr; 1(8381):854-6. PubMed ID: 6143169
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
    Grundy SM
    Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of determining serum cholesterol levels in patients with coronary heart disease].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diet and coronary heart disease: NHF review.
    Partenyi ZV
    Med J Aust; 1979 Dec; 2(13):696-7. PubMed ID: 393986
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins in the prevention of coronary heart disease.
    Williamson DR; Pharand C
    Pharmacotherapy; 1998; 18(2):242-54. PubMed ID: 9545143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of cholesterol-lowering therapy on the results of coronary arterial stenting in patients with chronic forms of coronary heart disease].
    Arablinskiĭ AV; Zakharova OV; Ioseliani DG
    Klin Med (Mosk); 2006; 84(7):13-6. PubMed ID: 16924793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
    Vessby B; Lithell H; Boberg J
    Artery; 1981; 9(5):372-81. PubMed ID: 7032466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary prevention of coronary disease with lipid-lowering drugs.
    Lancet; 1989 Mar; 1(8636):473-4. PubMed ID: 2563844
    [No Abstract]   [Full Text] [Related]  

  • 11. Coronary prevention study yields proof of cholesterol link.
    Schrott HG
    Iowa Med; 1984 Apr; 74(4):143-6. PubMed ID: 6376416
    [No Abstract]   [Full Text] [Related]  

  • 12. National service framework for coronary heart disease. Target of lowering cholesterol by 30% needs to be justified.
    Cracknell P
    BMJ; 2000 Sep; 321(7261):634. PubMed ID: 11023319
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum cholesterol and older people.
    Cohen DL; Mindell J
    Br J Hosp Med; 1991 Nov; 46(5):323-5. PubMed ID: 1958932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and risks of lowering serum cholesterol.
    Verschuren WM
    Epidemiology; 1997 Mar; 8(2):120-2. PubMed ID: 9229199
    [No Abstract]   [Full Text] [Related]  

  • 16. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.
    LIPID Study Group (Long-term Intervention with Pravastatin in Ischaemic Disease)
    Lancet; 2002 Apr; 359(9315):1379-87. PubMed ID: 11978335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effect of halofenate on serum lipids.
    Aronow WS; Vangrow J; Pagano J; Khemka M; Vawter M; Papageorge's NP
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):897-903. PubMed ID: 4214664
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.